کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2028284 | 1070408 | 2012 | 9 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Current concepts in glucocorticoid resistance Current concepts in glucocorticoid resistance](/preview/png/2028284.png)
Glucocorticoids (GCs) are the most potent anti-inflammatory agents known. A major factor limiting their clinical use is the wide variation in responsiveness to therapy. The high doses of GC required for less responsive patients means a high risk of developing very serious side effects. Variation in sensitivity between individuals can be due to a number of factors. Congenital, generalized GC resistance is very rare, and is due to mutations in the glucocorticoid receptor (GR) gene, the receptor that mediates the cellular effects of GC. A more common problem is acquired GC resistance. This localized, disease-associated GC resistance is a serious therapeutic concern and limits therapeutic response in patients with chronic inflammatory disease. It is now believed that localized resistance can be attributed to changes in the cellular microenvironment, as a consequence of chronic inflammation. Multiple factors have been identified, including alterations in both GR-dependent and -independent signaling downstream of cytokine action, oxidative stress, hypoxia and serum derived factors. The underlying mechanisms are now being elucidated, and are discussed here. Attempts to augment tissue GC sensitivity are predicted to permit safe and effective use of low-dose GC therapy in inflammatory disease.
► Glucocorticoids (GCs) are the most potent anti-inflammatory agents known.
► GC action is mediated by glucocorticoid receptor (GR) at the cellular level.
► GC resistance presents in both disease-specific and generalized manner.
► Development of GC resistance models is essential for screening new GR modulators.
► Safe and effective GC therapy may be achieved if GC sensitivity could be improved.
Journal: Steroids - Volume 77, Issue 11, September 2012, Pages 1041–1049